go back

GLUTARIC ACIDURIA II (MADD, ETF)

GLUTARIC ACIDURIA II (MADD, ETF)
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD
231680
OMIM = Online Mendelian Inheritance of Men
26791
electron transfer flavoproteine (ETF), ETF-ubiquinone oxireductase, electron transfer flavoprotein dehydrogenase
1.5.5.1
15q24.2-q24.3, 19q13.41, 4q32.1
E71.3
rare
autosomal recessive
mutations in 3 different genes: ETFA (IIA), ETFB (IIB), ETFDH (IIC)
3 forms:
 1) neonatal onset with congenital anomalies
 2) neonatal onset without congenital anomalies
 3) mild form, late onset
Criteria to distinguish dicarboxylic aciduria originating from MCT feeding and other conditions are needed in urinary organic acid profiling for detecting inborn errors of metabolism [Tserng KY 1996]
FLAD1 variants as a cause of potentially treatable inborn errors of metabolism manifesting with MADD [Olsen RKJ et al. 2016]
Laboratory findingsAdipic acid inc (urine)
Ketone bodies (urine) inc (urine)
Sebacic acid normal/inc (urine)
Suberic acid inc (urine)
 Ethylmalonic acid inc (urine)
   Isovaleroylglycine inc (urine)
    2-Methylbutyric Acid inc (urine)
    2-Methylbutyrylglycine normal/inc (urine)
    3-Hydroxyisovaleric acid inc (urine)
    4-Hydroxybutyric acid inc (urine)
    5-Hydroxyhexanoic acid inc (urine)
    Acylcarnitine (C2) inc (urine)
    Ammonia inc (blood)
    Butyryl/Isobutyrylcarnitine (C4) inc (blood)
    Butyrylglycine inc (plasma)
    Butyrylglycine inc (blood)
    Butyrylglycine inc (urine)
    Creatine kinase inc (plasma)
    D-Glucose dec (serum)
    Decanoylcarnitine (C10) inc (blood)
    Dicarboxylic acids inc (urine)
    Dodecanoylcarnitine (C12) inc (blood)
    Glutaric acid inc (urine)
    Glutarylcarnitine (C5DC) n/i (dried blood spot (DB)
    Hexanoylcarnitine (C6) inc (blood)
    Hexanoylcarnitine (C6) inc (urine)
    Hydroxyproline inc (urine)
    Isobutyric acid inc (urine)
    Isobutyrylglycine inc (urine)
    Isovaleric acid inc (urine)
    L-Lactic acid inc (urine)
    L-Lysine inc (urine)
    Octanoylcarnitine (C8) inc (blood)
    Palmitoylcarnitine (C16) inc (blood)
    pH normal/dec (blood)
    Proline inc (urine)
    Sarcosine normal/inc (urine)
    Tetradecanoylcarnitine (C14)/Propionylcarnitine (C3) inc (blood)
Symptomscardiomyopathy
coma
liver involvement or dysfunction
rhabdomyolysis
  polycystic kidneys
   cardiomyopathy, hypertrophic
   episodic course (metabolic findings)
   hyperammonemia
   hypotonia
   liver, fatty
   metabolic acidosis
   multicystic dysplastic kidneys
   myopathy
   pericardial effusion
   vomiting
    Amino acids, plasma
    Amino acids, urine
    dysmorphism
    early death
    exercise intolerance
    feeding difficulties, poor feeding
    flat depressed nasal bridge (saddle nose)
    hepatomegaly (large liver)
    hypoglycemia
    hypospadia
    hypothermia
    intrauterine growth retardation
    lactic acidosis
    liver steatosis
    low set ears
    MRI, brain, abnormalities [-]
    MRI, brain, white matter abnormalities [-]
    MRS, brain, abnormalities
    muscle weakness
    neuropathy
    onset, adolescent
    onset, adulthood
    onset, childhood
    onset, infancy
    onset, neonatal
    Organic acids, urine
    pain, muscle
    pancreatitis
    polyhydramnion (maternal)
    prominent forehead
    renal cysts
    seizures
    small for gestational age (SGA), intrauterine growth retardation (IUGR)